Licensed Publisher Agreement definition

Licensed Publisher Agreement or “LPA” means a valid and current license agreement for the publishing, development, manufacture, marketing, advertising, distribution and sale of Licensed Products, fully executed between a Licensed Publisher and an Affiliate.
Sample 1Sample 2Sample 3
Licensed Publisher Agreement or "LPA" means a valid and current agreement or renewal thereof between a Licensed Publisher and SCEA.
Sample 1Sample 2Sample 3
Licensed Publisher Agreement means a valid and current license agreement authorizing the publishing of software for any System, fully executed between a Licensed Publisher and an SIE Company, including any Global Developer and Publisher Agreement.
Sample 1Sample 2

Examples of Licensed Publisher Agreement in a sentence

  • Further, Publisher shall not sub-publish such PlayStation 2 format Software through a third party either within or outside the Licensed Territory unless and until such sub-publisher shall be authorised and licensed so to do either pursuant to a current PlayStation 2 Licensed Publisher Agreement with SCEE or a current PlayStation 2 licence agreement with the applicable Affiliate of SCEE.

  • Further, Publisher shall not sub-publish PSP format Software or Licensed Products through a third party either within or outside the Licensed Territory unless and until such sub-publisher shall be authorised and licensed so to do either pursuant to a current PSP Licensed Publisher Agreement with SCEE or a current PSP licence agreement with the applicable Affiliate of SCEE.

  • Developer shall not have the right to develop, publish, manufacture, have manufactured, market, promote, distribute, sell or transmit Sony Materials, the Executable Software and/or the Licensed Products in any manner unless Developer meets the criteria set forth in this Section or directly enters into a Licensed Publisher Agreement with SCEA.

  • The Rider’s terms and conditions are incorporated into and read in conjunction with the terms and conditions of the PlayStation Portable PSP Licensed Publisher Agreement Signed by Publisher (“PSP LPA”) along with any and all other riders to the PS2 LPA executed between Publisher and SCEA.

  • Dear Lxxxxx : This Letter Agreement amends the PlayStation®2 CD-ROM/DVD-ROM Licensed Publisher Agreement, effective as of April 1, 2000 (“PS2 LPA”) between Sony Computer Entertainment America Inc.

  • Xxxxxxx Print Name: Title: SVP-SCEA Title: Date: Date: This North American Territory Rider to the Global PlayStation®3 Format Licensed Publisher Agreement (the “Rider” or “North American Rider”) is entered into and rendered effective as of this 5th day of March, 2007 (the “Effective Date”).

  • A high ethical integrity is at our heart and we aim to work with sincerity and honesty, treating everyone in a respectful and fair manner.

  • Further, Publisher shall not sub-publish such PlayStation2 format Software through a third party either within or outside the Licensed Territory unless and until such sub-publisher shall be authorised and licensed so to do either pursuant to a current PlayStation 2 Licensed Publisher Agreement with SCEE or a current PlayStation 2 licence agreement with the applicable Affiliate of SCEE.

  • Further, Publisher shall not sub: publish such PlayStation 2 format Software through a third party either within or outside the Licensed Territory unless and until such sub-publisher shall be authorised and licensed so to do either pursuant to a current PlayStation 2 Licensed Publisher Agreement with SCEE or a current PlayStation 2 licence agreement with the applicable Affiliate of SCEE.

  • Rider to the Global PlayStation 3 Format Licensed Publisher Agreement, dated December 17, 2008, by and between EA International (Studio and Publishing) Limited and Sony Computer Entertainment Europe Limited.


More Definitions of Licensed Publisher Agreement

Licensed Publisher Agreement or "LPA" means a valid and current license agreement for the publishing, development, manufacture, marketing, advertising, distribution and sale of Licensed Products, fully executed between a Licensed Publisher and an Affiliate.
Sample 1
Licensed Publisher Agreement or "LPN' means a valid and current agreement or renewal thereof between a Licensed Publisher and SCEA or an equivalent such agreement between Publisher and an Affiliate of SCEA (e.g. the LPA with SCEE).
Sample 1
Licensed Publisher Agreement or "LPA" means a valid and current license agreement for the publication, development, manufacture, marketing,
Sample 1

Related to Licensed Publisher Agreement

  • Collaborative pharmacy practice agreement means a written and signed

  • Collaborative practice agreement means a written agreement

  • Licensed Programs means, collectively, NeoSystems’ and any Third Party Vendor computer software programs to be provided to Client for use on certain hardware on Client’s premises or a third party’s premises as set forth in an Agreement. The Licensed Programs shall include any fixes, work-arounds, updates, revisions, modifications, enhancements and any derivative works that are provided to Client by NeoSystems under an Agreement.

  • Marketing Materials has the meaning ascribed thereto in NI 41-101;

  • License Agreement means the agreement between SAP (or an SAP SE Affiliate, or an authorized reseller) under which Customer procured the rights to use SAP Software or a Cloud Service.

  • Technology License Agreement means the agreement in the form of Exhibit H hereto.

  • Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • Research Agreement means a new written contract, grant or cooperative agreement entered into between a person and a college or research corporation for the performance of qualified research; however, all qualified research costs generating a rebate must be spent by the college or research corporation on qualified research undertaken according to a research agreement.

  • Patent License Agreement means the Patent License Agreement substantially in the form of Exhibit C.

  • Core Curriculum Content Standards means the New Jersey Student Learning Standards.

  • Licensed Marks means those MLS GRID and MLS trademarks, service marks, word marks, logos and distinctive marks of all other kinds, if any, set out in Exhibit A as Licensed Marks.

  • Licensed Nurse means an Oregon licensed practical or registered nurse.

  • obsrvd_agnt_cd ;"count erparty_identifier";"entty_rl";"cntrct_id";"instrmnt_id";" reporting_reference_date" Alpha-numeric Semicolon-separated string of all column names. Field names are put in double quotation marks. 1 reporting_agent_identifier Variable characters (60) 60 identifier domain 2 obsrvd_agnt_cd Variable characters (60) 60 identifier domain 3 counterparty_identifier Variable characters (60) 60 identifier domain 4 entty_rl Variable characters (25) 25 counterparty-instrument role type 5 cntrct_id Variable characters (60) 60 identifier domain 6 instrmnt_id Variable characters (60) 60 identifier domain 7 reporting_reference_date Date reporting reference date

  • Software License Agreement means the Motorola Software License Agreement (Exhibit A).

  • Computer software documentation means owner's manuals, user's manuals, installation instructions, operating instructions, and other similar items, regardless of storage medium, that explain the capabilities of the computer software or provide instructions for using the software.

  • End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.

  • Publisher means any person or entity that distributes copies of the Document to the public.

  • Licensed Trademarks means the trademarks, service marks, trade dress, logos and other icons or indicia designated by SCEA in the SourceBook 2 or other Guidelines for use on or in connection with Licensed Products. Nothing contained in this Agreement shall in any way grant Publisher the right to use the trademark "Sony" in any manner. SCEA may amend such Licensed Trademarks from time to time in the SourceBook 2 or other Guidelines or upon written notice to Publisher.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • the Licensee means the person(s) named in the licence.

  • Licensed Software includes error corrections, upgrades, enhancements or new releases, and any deliverables due under a maintenance or service contract (e.g., patches, fixes, PTFs, programs, code or data conversion, or custom programming).

  • Common Channel Signaling (CCS) means an out-of-band, packet-switched, signaling network used to transport supervision signals, control signals, and data messages. It is a special network, fully separate from the transmission path of the public switched network. Unless otherwise agreed by the Parties, the CCS protocol used by the Parties shall be SS7.

  • Licensed Materials means any materials that Executive utilizes for the benefit of the Company (or any Subsidiary thereof), or delivers to the Company or the Company’s Customers, which (a) do not constitute Work Product, (b) are created by Executive or of which Executive is otherwise in lawful possession and (c) Executive may lawfully utilize for the benefit of, or distribute to, the Company or the Company’s Customers.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.